the power of
resolution
Ventus is expanding the frontier
for structure-based drug design
to conquer elusive targets.
For targets that are beyond
reach or underexploited,
our platforms reveal
the unmarked paths to druggability. new medicines.

company
metrics

  • 1
    resolute team
  • 100s of diverse hits
    for undruggable
    targets
  • 1st company
    to solve innate
    immune protein
    structures
  • $150 million
    in financing
    in 1 year
  • Billions of compounds
    screened without
    pre-existing
    chemical matter
  • 5 pipeline programs
    in 3 therapeutic
    areas
  • 4 founders
    on the National
    Academy of
    Science
Our resolve is to make everyday moments possible for patients.

View Our Pipeline